R&Dplatform

Contact Us

 

 

  

Address: Beijing's xizhimen south street, xicheng district

 

The British garden 1 floor. Room 824

 

Zip code: 100035

 

Telephone: 010-58562339

 

Fax: 010-58562339

 

Email address: cngjzj@163.com

 

Web site (click on the url link directly left) :

 

http://www.cngjzj.com/

 

Blog (click on the url link directly left) :

http://blog.sina.com.Cn/CNGJZJ

 

To xizhimen south street, xicheng district building to the British garden route

L airport line 1

Take the airport shuttle from the airport, the dongzhimen station transfer to metro line 2 to xizhimen direction and get off at xizhimen station, from C outbound, go straight to the east 100 meters on the right side to xizhimen south street, north to walk to the t-junction namely to the British garden 1 floor downstairs.

L airport line 2

From the capital airport take airport bus to xidan, get off at no.22, take a taxi to xizhimen south street English garden 1 floor.

L bus subway near:

106 bus GuanYuan: 107 road, express way

Bus: xizhimen south road 387, 44 road, inner ring 800, 816 road, inner ring 820, 845 road

Che zhuang: subway line two

Xizhimen subway: metro line 2

Buses and attempts: 107 road, 118 road, 701 road

Buses and north zhuang: 209 road, 375 road, 392 road

 

Your position is: Home >> R&Dplatform >> R&Dplatform

Human medicinal center data extrapolation power children medicine research and development are put forward

2016年11月09日

复制链接 打印 大 中 小

<

 

 

Human medicinal center data extrapolation power children medicine research and development are put forward

On November 7, 2016

China pharmaceutical net

 

At present, China pharmaceutical industry dynamic 】 【 children medicine is faced with "no medical pediatrics", "adult medicine break half" awkward situation. Now, drug firms likely to use the data extrapolation to perfect and enrich pediatric population information.

Released on November 3, the adult dosage data extrapolation in the pediatric population of drug clinical trials and the relevant information of the technical guidelines "(draft), the human medicinal drug safety administration center (CDE) is put forward," as far as possible, reduce the pediatric population the number of subjects in drug clinical trials, through data extrapolation to improve drug pediatric population and rich information, to guide the clinical medication, become the important and necessary way of ensure the safety of children with drug use."

CDE also said that guidelines with emphasis on the concept and framework of the data extrapolation, pediatric population drug clinical trial data extrapolating the basic principles and requirements, provide the reference for the research and development enterprise.

"Considering the target group, the differences between the treatment and drug properties, data extrapolation method is its diversity and flexibility, this guiding principle only data extrapolation general considerations are put forward."

"Encourage the applicant in the pediatric population in the early stages of drug development and regulatory data extrapolation to communicate."

Research and development institutions should also reference drugs quality control standard for clinical trials (GCP), people with drug registration specification international coordination meeting (ICH) and other relevant guidelines require both at home and abroad, the CDE said.

This guideline is only on behalf of the drug regulatory agency of the current views and understanding, with the progress of the scientific research related content in this guideline will constantly improve, human medicinal center added.

Solicit opinions from the date of release as of two months. Can be in CDE fill send directly on site. (source: the healthy idea ihealth)